Watchlist Price Alert

Myriad Genetics Inc. (MYGN)

NASDAQ: MYGN · Real-Time Price · USD

3.98

-0.09 (-2.21%)

At close: May 22, 2025, 3:28 PM

Myriad Genetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Net Income	-263.3M	-112M	-27.2M	-223.7M	-199.5M	4.6M	133.3M	17.4M
Depreciation & Amortization	61.9M	52.7M	62.8M	71.4M	72M	73M	54.4M	48.3M
Stock-Based Compensation	40.7M	38.1M	36.3M	24.3M	25.2M	33.5M	27.1M	29.9M
Other Working Capital	28.7M	-84.8M	118.8M	n/a	63M	-30.3M	4.6M	13.3M
Other Non-Cash Items	23.4M	30.3M	-139.4M	70.9M	99.2M	-1.1M	-83.6M	3M
Deferred Income Tax	-600K	-31.9M	-34.7M	-54.5M	-54.1M	13.1M	-23.8M	2M
Change in Working Capital	27M	-83.5M	120.8M	30.2M	117.9M	-39.4M	8.5M	5.6M
Operating Cash Flow	-110.9M	-106.3M	18.6M	-26.9M	60.7M	83.7M	115.9M	106.2M
Capital Expenditures	-73.3M	-45.3M	-18M	-13.2M	-10.2M	-8.6M	-8.4M	-6.1M
Cash Acquisitions	n/a	-57.2M	379.1M	n/a	21.3M	-278.5M	n/a	-216.1M
Purchase of Investments	n/a	-103.2M	-147.8M	n/a	-60.8M	-78.5M	-80.9M	-87.5M
Sales Maturities Of Investments	105.2M	128.2M	61.1M	n/a	69M	79.2M	77.7M	163.4M
Other Investing Acitivies	n/a	n/a	n/a	74.8M	n/a	n/a	n/a	n/a
Investing Cash Flow	31.9M	-77.5M	274.4M	61.6M	19.3M	-286.4M	-11.6M	-146.3M
Debt Repayment	39.8M	n/a	-226.4M	n/a	-8.6M	225M	-90M	98M
Common Stock Repurchased	n/a	n/a	n/a	-3.9M	n/a	-50M	n/a	-31.6M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-4.5M	-8M	75.8M	11.5M	-1.4M	7.3M	-5M	5.4M
Financial Cash Flow	152.9M	-8M	-150.6M	-1M	-10M	182.3M	-95M	71.8M
Net Cash Flow	74.5M	-192.4M	141.8M	70.5M	70.5M	-17.7M	8.5M	33.9M
Free Cash Flow	-184.2M	-151.6M	600K	-40.1M	50.5M	75.1M	107.5M	100.1M